Key facts
- This page summarizes Barry Ticho's Form 3 filing for Verve Therapeutics, Inc. (VERV).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 16 Jun 2021, 19:31.
Barry Ticho - 16 Jun 2021 Form 3 Insider Report for Verve Therapeutics, Inc. (VERV)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- VERV
- Reported as of
- 16 Jun 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 16 Jun 2021, 19:31:11 UTC
- Next SEC filing
- 15 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew Ashe, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Barry Ticho filed Form 3 for Verve Therapeutics, Inc. (VERV) on 16 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VERV
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 409,626
- Date
- 16 Jun 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit Index: 24.1 Power of Attorney